AUIC - The universal parameter within the constraint of a reasonable dosing interval

被引:47
作者
Schentag, JJ [1 ]
Nix, DE [1 ]
Forrest, A [1 ]
Adelman, MH [1 ]
机构
[1] MILLARD FILLMORE HOSP,CLIN PHARMACOKINET LAB,BUFFALO,NY 14209
关键词
D O I
10.1177/106002809603000920
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1029 / 1031
页数:3
相关论文
共 29 条
[1]  
BALLOW CH, 1993, 33 INT C ANT AG CHEM, P134
[2]   PHARMACODYNAMICS OF AMIKACIN INVITRO AND IN MOUSE THIGH AND LUNG INFECTIONS [J].
CRAIG, WA ;
REDINGTON, J ;
EBERT, SC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 :29-40
[3]  
DallaCosta T, 1996, ANN PHARMACOTHER, V30, P1024
[4]  
DRUSANO GL, 1991, SCAND J INFECT DIS S, V74, P235
[5]   PHARMACODYNAMICS AND PHARMACOKINETICS OF ANTIBIOTICS WITH SPECIAL REFERENCE TO THE FLUOROQUINOLONES [J].
DUDLEY, MN .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S45-S50
[6]   PHARMACODYNAMICS OF INTRAVENOUS CIPROFLOXACIN IN SERIOUSLY ILL-PATIENTS [J].
FORREST, A ;
NIX, DE ;
BALLOW, CH ;
GOSS, TF ;
BIRMINGHAM, MC ;
SCHENTAG, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :1073-1081
[7]  
FORREST A, 1993, 33 INT C ANT AG CHEM, P134
[8]   MATHEMATICAL EXAMINATION OF DUAL INDIVIDUALIZATION PRINCIPLES .2. THE RATE OF BACTERIAL ERADICATION AT THE SAME AREA UNDER THE INHIBITORY CURVE IS MORE RAPID FOR CIPROFLOXACIN THAN FOR CEFMENOXIME [J].
GOSS, TF ;
FORREST, A ;
NIX, DE ;
BALLOW, CH ;
BIRMINGHAM, MC ;
CUMBO, TJ ;
SCHENTAG, JJ .
ANNALS OF PHARMACOTHERAPY, 1994, 28 (7-8) :863-868
[9]  
HIGHET VS, 1994, POPULATION DERIVED A
[10]   PHARMACOKINETIC AND PHARMACODYNAMIC ACTIVITIES OF CIPROFLOXACIN AGAINST STRAINS OF STREPTOCOCCUS-PNEUMONIAE, STAPHYLOCOCCUS-AUREUS, AND PSEUDOMONAS-AERUGINOSA FOR WHICH MICS ARE SIMILAR [J].
HYATT, JM ;
NIX, DE ;
SCHENTAG, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (12) :2730-2737